Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Updated on: October 05,2025 0

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Updated on:October 05,2025 0

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

Updated on: October 05,2025 0

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

Updated on:October 05,2025 0

Gene-edited immune cells show promise for universal 'off-the-shelf' cancer therapy

Updated on: October 05,2025 0

Gene-edited immune cells show promise for universal 'off-the-shelf' cancer therapy

Updated on:October 05,2025 0

Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

Updated on: October 05,2025 0

Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

Updated on:October 05,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on: October 05,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on:October 05,2025 0

Blocker drugs may defeat a problematic protein in synovial sarcoma's genes

Updated on: October 05,2025 0

Blocker drugs may defeat a problematic protein in synovial sarcoma's genes

Updated on:October 05,2025 0

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Updated on: October 04,2025 0

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Updated on:October 04,2025 0

Proof-of-concept innate immune checkpoint inhibitor shows promise against solid tumors in rodents

Updated on: October 04,2025 0

Proof-of-concept innate immune checkpoint inhibitor shows promise against solid tumors in rodents

Updated on:October 04,2025 0

How does chemotherapy disrupt circadian rhythms?

Updated on: October 04,2025 0

How does chemotherapy disrupt circadian rhythms?

Updated on:October 04,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on: October 04,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on:October 04,2025 0